Skip to content

Effect of the Peri-incisional Multimodal Cocktail Infiltration on Postcraniotomy Headache

Effect of the Peri-incisional Multimodal Cocktail Infiltration on Postcraniotomy Headache

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03915639
Enrollment
100
Registered
2019-04-16
Start date
2022-04-30
Completion date
2023-12-31
Last updated
2020-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

Post-Craniotomy Headache, Postoperative Pain, Cocktail, Analgesia

Brief summary

Postcraniotomy headache (PCH) has been underestimated for the past decades. However, current treatments for PCH are either considered insufficient or accompanied by severe side-effects. Some studies revealed that peri-incisional injection of a mixed cocktail that contains ropivacaine, epinephrine, ketorolac, and methylprednisolone showed significant efficacy in relieving postoperative pain after total hip or knee arthroplasty. Previous literature reported that the cause of PCH was related to incision of the scalp and dura, which is considered similar to causes to postoperative pain after total hip or knee arthroplasty. Thus, investigators suppose that the cocktail mixture can better relieve PCH in adults.

Interventions

PROCEDUREPeri-incisional injection

The surgeons are planned to inject the cocktail mixture or ropivacaine to muscles and the subcutaneous tissue beneath the fixation sites and incision site using a 22-gauge needle in a sterile fashion prior to skin incision.

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Having signed the informed consent, 2. age 18-80 yrs, 3. American Society of Anaesthesiologists (ASA) physical status of I or II, 4. scheduled elective supratentorial craniotomy, 5. planned head fixation in a skull clamp.

Exclusion criteria

1. Allergy to LAs, 2. alcohol abuse, 3. intracranial hypertension, 4. active psychiatric disorders, 5. uncontrolled epilepsy, 6. chronic opioid use (more than 2 weeks), 7. undergoing a revision craniotomy, 8. high probability of having postoperative radio- or chemotherapy, 9. expectation of delayed extubation or no planned extubation, 10. pregnancy or breastfeeding during the study, 11. extreme body mass index (BMI) (less than 15 or more than 40), 12. preoperative Glasgow Coma Scale less than 15, 13. undergoing emergency or awake craniotomy surgery, 14. inability to understand the use of the NRS or the PCA. (Patients are informed of the instructions of NRS (from 0 to 10, where 0 and 10 represent no pain and the worst imaginable pain, respectively) and PCA after signing the informed consent the day before the operation. Patients who cannot understand the instruction of NRS and PCA will be excluded from the study.)

Design outcomes

Primary

MeasureTime frameDescription
Cumulative morphine consumption24 hours after recoverycumulative morphine consumption through PCA within 24 hours after recovery

Secondary

MeasureTime frameDescription
Rate of post-operative opioid-related side effects1, 2, 4, 6, 12, 24, 48 and 72 hours after recoveryPost-operative opioid-related side effects include post-operative opioid-induced oversedation, opioid-induced respiratory depression, pruritus, drowsiness, dizziness, blurred vision, and rash. Opioid-induced oversedation will be evaluated using the Pasero Opioid-induced Sedation Scale (POSS). 1. Awake and alert, 2. Slightly drowsy, easily aroused, 3. Frequently drowsy, arousable, drift off to sleep during a conversation, 4. Somnolent, minimal or no response to verbal or physical stimulation A POSS score of 3 or 4 is defined as oversedation. Opioid-induced respiratory depression (defined as respiratory rate \<8/min and/or oxygen saturation \<90% and/or apnoea ≥10 s, excessive sedation or upper airway obstruction.
Time interval to first PCA demandwithin 24 hours after recoveryThe PCA device will automatically record the time interval to the first PCA demand based on a specially designed algorithm
Total PCA press countswithin 24 hours after recoveryThe PCA device will automatically record the total press counts based on a specially designed algorithm.
Total rescue medication usagewithin 24 hours after recoveryWhen PCA is not enough for analgesia, rescue medication will be used for relieving severe pain. The total rescue medication usage within 24 hours after recovery will be recorded.
Recoveryan average of 1 monthTime to PACU discharge, time to ambulation, and length of stay (LOS)
Postoperative 0-10 Numeric Rating Score1, 2, 4, 6, 12, 24, 48 and 72 hours after recovery and 3 and 6 months after craniotomyNumeric Rating Score is a common used scale in evaluating patients' pain intensity in clinical trials. The scale in the present trial is ranged from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher values represent worse pain intensity.
The size of surgical incisionat the end of the craniotomyRecording the size of surgical incision (unit: centimeter)
The duration of operationat the end of the craniotomyRecording the duration of operation (unit:minute)
Rate of postoperative complicationswithin 30 days after craniotomyPostoperative complications include (1) Operative complications: intracranial infection, cerebral oedema, intracranial haematoma, CSF fistula, reoperation, reintubation and delayed extubation. incision infection, incision haematoma, delayed wound healing; (2) systemic complications: systemic infection, systemic inflammatory response syndrome and sepsis; (3) all-cause mortality
Postoperative antibiotic usagewithin 30 days after craniotomypostoperative antibiotic usage
Wound Healing Score3 and 6 weeks after craniotomyWound Healing Score worksheet for assessment of outcomes in scalp clip versus artery forceps groups in patients undergoing craniotomy. The wound healing evaluation is based on skin healing, infection and hair regrowth. For skin healing, 1 represents fully healed, 2 represents ≤3 cm in total not healed, 3 represents \>3 cm not healed, 4 represents areas of necrosis ≤3 cm, and 5 represents areas of necrosis \>3 cm. For infection, 1 represents none, 2 represents ≤0.5-cm margin of redness , 3 represents more redness or superficial pus, 4 represents deep infection. For hair regrowth, 1 represents even regrowth along wound, 2 represents ≤3 cm not regrowing , 3 represents 3-6 cm not regrowing, 4 represents \>6 cm not regrowing. Excellent wounds, total score of 3; Good wounds, Score 4-5; Suboptimal wounds, Score 6+

Contacts

Primary ContactFang Luo
13611326978@163.com+86 13611326978
Backup ContactZheng Chen
zchan1011@yahoo.com+86 15010130151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026